It can be challenging to enact change across a complex healthcare environment. But implementing procalcitonin (PCT) testing in the emergency room (ER), intensive care unit (ICU), and beyond has real, lasting impact on patient management and can help curb the effects of antibiotic overuse and resistance.
Like any shift in process or procedure, implementation requires a well-thought-out plan and clearly defined strategy that includes:
Establishing PCT best practices can help healthcare leaders and clinicians:
Conduct appropriate PCT testing and apply correct interpretation, while putting results into the clinical context.
Avoid unnecessary testing.
Achieve desired clinical and health economic outcomes.
Similar to antibiotic stewardship programs, there is no one-size-fits-all approach to making changes to testing. But that doesn’t mean you have to go it alone, creating testing protocols from scratch.
Download the Implementation Guide to learn helpful information to start a successful PCT program in your hospital, including how to:
Central to the guide is the Plan-Do-Study-Act (PDSA) cycle, a framework for learning and action that can help your hospital get a PCT program up and running as quickly as possible.
Model for improvement: Plan-Do-Study-Act (PDSA) cycles1
You can have the most fool-proof plan and sophisticated strategy, but both will fail to deliver if they are not backed up by stakeholders who understand the true value of new testing protocols—including how to interpret results —and the ultimate goal of adoption. To make it work, also regional needs defined by specific patient mix, and healthcare environment, e.g. in Asia-Pacific, should be considered, as reflected by the expert consensus algorithms.2,3
That’s why it is vital to provide tailored education to all clinicians involved with procalcitonin testing.4 In fact, it is the key to successful implementation.5 The alternative path? Passive dissemination of the evidence and educational interventions, which are insufficient and do not offer sustainable solutions for laboratory test implementation.4,6 In addition, a lack of systemic education may lead to sub-optimal results.7
For an educational roll-out to be a successful part of your implementation strategy, you’ll need support. Our team is ready to help your healthcare system effect real change with the right knowledge from key opinion leaders, research studies, clinical evidence, and more. Let’s get to it.
- Dr. Michael Broyles, Director of Medical Affairs, Thermo Fisher Scientific.